Description

Spiolto Respimat (Tiotropium, Olodaterol) Solution for Inhalation 2.5 mcg/2.5 mcg. 4 ml. (60 doses) + Inhaler

Ingredients

Active ingredients: Tiotropium and Olodaterol.

Dosage

Recommended dosage: The usual dose is 2 puffs once daily.

Indications

Indicated for: Maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Contraindications

Do not use: In case of allergy to any of the ingredients or if you have asthma.

Directions

Usage: Inhale the medication as directed by your healthcare provider. Do not exceed the recommended dose.

Scientific Evidence

Tiotropium and Olodaterol have been extensively studied for their efficacy in managing COPD. Clinical trials have shown that the combination of these two medications provides superior bronchodilation and improves lung function compared to monotherapy. Research published in the American Journal of Respiratory and Critical Care Medicine demonstrated a significant reduction in exacerbations and improved quality of life in COPD patients using this combination therapy.

Additional Information

This inhaler is designed for long-term use and should be stored at room temperature away from moisture and heat. It is important to keep track of the number of doses used to ensure timely refills. Consult your healthcare provider for personalized advice on using Spiolto Respimat.

Pharmacologically, Tiotropium acts as a long-acting anticholinergic bronchodilator, while Olodaterol is a long-acting beta-adrenergic agonist. These two agents work synergistically to relax the airways and improve breathing in patients with COPD. The combination therapy targets different pathways in the lungs, providing a comprehensive approach to managing COPD symptoms.